7.4K views · 1.2K reactions | Learning futuristic updates, adapting to marketing trends! See a glimpse of what's in store ahead of the industry in this year's Juan Big Idea 2023: Advancing to the Future of Marketing. Ticket selling starts on February 8, 2023. Don't forget to follow Philippine Junior Marketing Association | PJMA to get first-hand updates. #GlimpseofTheFuture #JuanBigIdeaNationwide2023 | Philippine Junior Marketing Association | PJMA | Facebook

OS Therapies (NYSE American: OSTX) announced a regulatory update for OST-HER2, its osteosarcoma immunotherapy, for the prevention or delay of recurrent, fully resected, pulmonary metastatic osteosarcoma, with UK MHRA conditional Marketing Authorisation Application submission expected in December 2025 and US FDA Biologics Licensing Application submission under the Accelerated Approval Program planned for January 2026. OS Therapies is a B2i Digital Featured Company. View their comprehensive profil